Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, pharmacokinetics, and pharmacodynamics study of MK-8389 in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function.

Next Previous
Search
Trial Profile

Safety, pharmacokinetics, and pharmacodynamics study of MK-8389 in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Feb 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs MK 8389 (Primary)
  • Indications Infertility
  • Focus Adverse reactions; Pharmacokinetics

Most Recent Events

  • 04 Feb 2016 New trial record
  • 05 Jan 2016 Results published in the Fertility and Sterility

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top